Faden DL - Search Results

1

Immunotherapy time of infusion impacts survival in head and neck cancer: A propensity score matched analysis.

Ruiz-Torres DA, Naegele S, Podury A, Wirth L, Shalhout SZ, Faden DL. Ruiz-Torres DA, et al. Among authors: faden dl. Oral Oncol. 2024 Apr;151:106761. doi: 10.1016/j.oraloncology.2024.106761. Epub 2024 Mar 20. Oral Oncol. 2024. PMID: 38507992

2

The "closed-airway sneeze": an unusual cause of laryngeal fracture.

Faden DL, Elackatuu A, Platt M. Faden DL, et al. Otolaryngol Head Neck Surg. 2011 Sep;145(3):515-6. doi: 10.1177/0194599811402947. Otolaryngol Head Neck Surg. 2011. PMID: 21493278 No abstract available.

3

Correction: Whole Exome Sequencing of Growing and Non-Growing Cutaneous Neurofibromas from a Single Patient with Neurofibromatosis Type 1.

Faden DL, Asthana S, Tihan T, DeRisi J, Kliot M. Faden DL, et al. PLoS One. 2017 Feb 16;12(2):e0172620. doi: 10.1371/journal.pone.0172620. eCollection 2017. PLoS One. 2017. PMID: 28207875 Free PMC article.

4

Variation of BMP3 contributes to dog breed skull diversity.

Schoenebeck JJ, Hutchinson SA, Byers A, Beale HC, Carrington B, Faden DL, Rimbault M, Decker B, Kidd JM, Sood R, Boyko AR, Fondon JW 3rd, Wayne RK, Bustamante CD, Ciruna B, Ostrander EA. Schoenebeck JJ, et al. Among authors: faden dl. PLoS Genet. 2012;8(8):e1002849. doi: 10.1371/journal.pgen.1002849. Epub 2012 Aug 2. PLoS Genet. 2012. PMID: 22876193 Free PMC article.

5

Multi-modality analysis supports APOBEC as a major source of mutations in head and neck squamous cell carcinoma.

Faden DL, Thomas S, Cantalupo PG, Agrawal N, Myers J, DeRisi J. Faden DL, et al. Oral Oncol. 2017 Nov;74:8-14. doi: 10.1016/j.oraloncology.2017.09.002. Epub 2017 Sep 13. Oral Oncol. 2017. PMID: 29103756

6

APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma.

Faden DL, Ding F, Lin Y, Zhai S, Kuo F, Chan TA, Morris LG, Ferris RL. Faden DL, et al. Oral Oncol. 2019 Sep;96:140-147. doi: 10.1016/j.oraloncology.2019.07.020. Epub 2019 Jul 30. Oral Oncol. 2019. PMID: 31422205 Free PMC article.

7

Two for the price of one: Prevalence, demographics and treatment implications of multiple HPV mediated Head and Neck Cancers.

Strober W, Shishido S, Wood B, Lewis JS Jr, Kuhs K, Ferris RL, Faden DL. Strober W, et al. Among authors: faden dl. Oral Oncol. 2020 Jan;100:104475. doi: 10.1016/j.oraloncology.2019.104475. Epub 2019 Nov 22. Oral Oncol. 2020. PMID: 31765835 Free PMC article.

8

Immune checkpoint inhibitors in sinonasal squamous cell carcinoma.

Park JC, Faquin WC, Durbeck J, Faden DL. Park JC, et al. Among authors: faden dl. Oral Oncol. 2020 Oct;109:104776. doi: 10.1016/j.oraloncology.2020.104776. Epub 2020 May 12. Oral Oncol. 2020. PMID: 32414645 Free PMC article. No abstract available.

9

Treatment sequence of cetuximab and immune checkpoint inhibitor in head and neck squamous cell carcinoma differentially affects outcomes.

Park JC, Durbeck J, Clark JR, Faden DL. Park JC, et al. Among authors: faden dl. Oral Oncol. 2020 Dec;111:105024. doi: 10.1016/j.oraloncology.2020.105024. Epub 2020 Oct 13. Oral Oncol. 2020. PMID: 33065374

10

Prospective assessment of multiple HPV-positive oropharyngeal squamous cell carcinomas.

Faden DL, O'Boyle CJ, Lin DT, Deschler DG, Emerick KS, Varvares MA, Faquin WC, Sadow PM, Richmon JD. Faden DL, et al. Oral Oncol. 2021 Jun;117:105212. doi: 10.1016/j.oraloncology.2021.105212. Epub 2021 Feb 15. Oral Oncol. 2021. PMID: 33602576 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page